LINCOLN PHARMACEUTICALS
|
LINCOLN PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹100 Cr | ₹96 Cr | ₹84 Cr | ₹67 Cr | ₹62 Cr |
Adjustment | ₹-0.23 Cr | ₹1.48 Cr | ₹4.84 Cr | ₹8.66 Cr | ₹9.30 Cr |
Changes In working Capital | ₹-31 Cr | ₹2.40 Cr | ₹0.20 Cr | ₹14 Cr | ₹-1.12 Cr |
Cash Flow after changes in Working Capital | ₹69 Cr | ₹100 Cr | ₹89 Cr | ₹90 Cr | ₹70 Cr |
Cash Flow from Operating Activities | ₹39 Cr | ₹76 Cr | ₹69 Cr | ₹75 Cr | ₹53 Cr |
Cash Flow from Investing Activities | ₹-37 Cr | ₹-78 Cr | ₹-64 Cr | ₹-31 Cr | ₹-18 Cr |
Cash Flow from Financing Activities | ₹-4.50 Cr | ₹-2.56 Cr | ₹-5.75 Cr | ₹-38 Cr | ₹-36 Cr |
Net Cash Inflow / Outflow | ₹-1.88 Cr | ₹-4.50 Cr | ₹-0.70 Cr | ₹6.77 Cr | ₹-1.11 Cr |
Opening Cash & Cash Equivalents | ₹6.93 Cr | ₹11 Cr | ₹12 Cr | ₹5.46 Cr | ₹6.57 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹5.05 Cr | ₹6.93 Cr | ₹11 Cr | ₹12 Cr | ₹5.46 Cr |
Compare Cashflow Statement of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,157.4 Cr | 5.6% | -17.6% | 72.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,015.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,809.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,408.7 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹98,684.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,213.7 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | 5.6% |
-17.6% |
72.6% |
SENSEX | -2.9% |
-0.4% |
20% |
You may also like the below Video Courses